Investigational Gene Therapy Produced 2 Year Immunity Against HIV – Specialty Pharmacy Times
|
Investigational Gene Therapy Produced 2 Year Immunity Against HIV
Specialty Pharmacy Times In 2017, the FDA approved the very first gene therapy, tisagenlecleucel (Kymriah) for refractory B-cell precursor acute lymphoblastic leukemia, and subsequently approved axicabtagene ciloleucel (Yescarta) for diffuse large B-cell lymphoma and Luxturna … |
